This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Tue, 01/23/2024 - 13:50 January 23, 2024 — Bayer announced Nelson Ambrogio as the new Head of the Radiology Business at its Pharmaceuticals Division, effective April 1, 2024. He will report to Stefan Oelrich , Member of the Board of Management, Bayer AG, and President Pharmaceuticals.
milla1cf Wed, 10/11/2023 - 13:24 October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE), a Virginia, U.S.-based SOFIE and GE HealthCare will collaborate on both the development and commercialization processes through a joint steering committee. Sherly Mosessian , Ph.D,
milla1cf Tue, 04/02/2024 - 18:51 April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc. , GE HealthCare Technologies Inc. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.
of the Qualcomm Institute within the University of California San Diego , finds that question can be difficult to answer since AI products in healthcare do not universally undergo any externally evaluated approval process assessing how it might benefit patient outcomes before coming to market. A new study published in JAMA led by John W.
GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.
Participants were asked to answer questions pertaining to the healthcare system as a whole based on their personal experiences and observations. In a specialized field like healthcare, resolving that tension is complex and it starts by listening to those who are at the center of care,” said GE HealthCare President and CEO Peter Arduini.
We are delighted to see the inclusion of Cerianna PET in the NCCN breast oncology guidelines, for potential use when oncologists are evaluating metastatic breast cancer patients,” Dr. Mark Hibberd, Chief Medical Officer at GE HealthCare’sPharmaceutical Diagnostics segment, said. J Natl Compr Canc Netw.
milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Contact your GE HealthCare or MediView sales representative to learn more.
GE HealthCare reported 1% growth in organic revenues and a slight increase in profitability in its second quarter of 2024. For the period (end-June 30), GE HealthCare had total revenues of $4.839 billion, flat compared with $4.817 billion in the in the same period last year. last year to 15.3% in the second quarter this year.
GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. On an individual segment basis, GE HealthCare's Imaging segment had flat revenues year over year of $2.22 last year to 16.3%
-based radioisotope production is already helping to meet a vital need for patients, and the Company is strongly positioned for sustained rapid growth as we pioneer new horizons to help meet patients’ healthcare needs with game-changing radiopharmaceuticals.” In 2022, he was promoted to President and Chief Operating Officer. He holds a Ph.D.
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. GE HealthCare's new Revolution Ascend CT scanner. GE HealthCare's Signa Champion 1.5-tesla tesla scanner.
milla1cf Thu, 11/02/2023 - 13:52 November 2, 2023 — GE HealthCare’s Artificial Intelligence ( AI ) models predict patient response to immunotherapies with 70 to 80 percent accuracy [1] , based on a pan-cancer cohort, according to findings to be presented at the Society for Immunotherapy of Cancer ( SITC ) in San Diego, U.S.,
For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market.
This collaboration is a significant step forward in our mission to support healthcare providers and patients by providing high-quality medical isotopes. An active DMF enables clinical investigators or pharmaceutical companies to reference the filing in their regulatory submissions.
Produced by the ACR Committee on Drugs and Contrast Media, the new manual features four updates: An update and addition of Ferumoxytol as a new MRI contrast medium for Chapter 12 – Contrast Media in Children An update for Chapter 13 - Gastrointestinal (GI) Contrast Media in Adults: Indications and Guidelines An evidence-based update with recommendations (..)
I look forward to building new relationships and expanding our collaborations with companies that seek reliable therapeutic radioisotopes supply or Radiopharmaceutical CDMO/CMO services, to help them meet patients’ healthcare needs.” Francis in Joliet, Ill., and a Bachelor of Science degree from Jacksonville State University.
Many market segments enjoy unprecedented job growth, but none more than the healthcare sector. The BLS found that the healthcare and social assistance sector will add around 2.1 It’s an excellent time for skilled healthcare workers to look for a job. Multiple factors led to this moment in healthcare recruitment.
mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) For further information visit: [link] [4] FASTlab is a trademark of GE Healthcare and its affiliates. [5] The PDUFA[2] goal date is March 24, 2025. 2] Prescription Drug User Fee Act. [3]
Hospitals and healthcare organizations are currently struggling to fill many positions. The demand for healthcare professionals is projected to outpace the supply. The following are seven tips for successful healthcare recruiting. Implementing the best recruitment strategies is crucial to filling these openings.
Healthcare has dominated headlines for the better part of the last twenty years. Whether it’s proposals for large-scale reform like the Affordable Care Act or, more recently, the constant news updates surrounding the COVID-19 Pandemic, we are all invested in and impacted by the healthcare news cycle. Promising clinical trials.
Emery has more than 30 years of experience in financial executive leadership in the pharmaceutical and medical device industries. Prior to that, he led financial executive teams at Plasma Surgical and Abbott Pharmaceuticals. He was previously CFO and chief operating officer (COO) at Tyber Medical.
In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. and global healthcare.” Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs).
Leveraging Doceree's patented triggers technology, the innovative suite of Spark uses advanced AI capabilities to tackle critical challenges within the healthcare domain, including patient affordability and drug adherence, patient recruitment in clinical trials, effective clinical messaging on pharmaceutical innovations.
Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., according to a written statement announcing the appointment. “I
Even with recent promising pharmaceutical developments, treating neurodegenerative diseases depends on the timely identification of prospective candidates for early intervention who can benefit from this drug that extends their quality of life by several months to several years.
The FibroScint program, a collaboration with Capella Imaging, to develop a Tc-99m agent to image fibrin, and collaboration with GE Healthcare to manufacture I-123 capsules are on track for further advancement this year. In parallel with these initiatives, NorthStar’s imaging portfolio continues to advance,” Mr. Merrick further added.
Google has released Health AI Developer Foundations (HAI-DEF), a new open resource designed to enable developers to efficiently build and implement AI models for healthcare att every stage of development, from early research to commercial ventures, according to Google.
He brings more than 25 years of experience from GE HealthCare (GEHC), where he served for 25 years in a variety of roles, including executive director and global head of contrast media; general manager, pharmaceutical diagnostics North America; and president.
Experts have long explored computer algorithms meant to improve healthcare, with some having been shown to make valuable clinical predictions. Programs like NYUTron can alert healthcare providers in real time about factors that might lead to readmission and other concerns so they can be swiftly addressed or even averted."
The ultimate aim is to build a digital healthcare tool that radiologists can use when scanning for other conditions to determine a person’s dementia risk, and to diagnose early stages of related diseases, such as Alzheimer’s.
They noted the world’s top global tech and pharmaceutical companies have set up in the country and are major contributors to state coffers via their taxes. Read more at Enterprise Ireland hunts for hidden unicorns | Financial Times.
For CT and MRI procedures where injected contrast media is ordered, ". These examples represent a growing acceptance across the country of radiologists conducting direct supervision of radiologic technologists performing intravenous contrast media administration via A/V real-time communications technology," ASBME said.
Indian government has taken definitive steps towards inclusive healthcare committing to make India healthier and a model to be emulated by the rest of world. Government schemes like ‘Ayushman Bharat,’ allocates funds towards improving healthcare infrastructure in Tier 2 and 3 cities along with rural areas.
Healthcare is a fast-evolving landscape driven by transforming technologies and shifting user requirements. Healthcare must revolve around the needs of the patient or end user. The need for more remotely accessible services like telemedicine and a range of advanced medical devices is accelerating growth across the industry.
Effective monitoring of treatment response is crucial in managing steatotic liver disease, as it allows healthcare providers to adjust therapeutic interventions based on individual patient needs. This is because in approving Rezdiffra, the FDA said a liver biopsy was not needed to begin treatment.
But grappling with NSF after the fact may be the least troubling issue as healthcare experts scramble to figure out why some patients develop NSF -- and what they can do to prevent NSF from occurring in the first place. Short of a kidney transplant, NSF is difficult to manage. Giles, U.K. Omniscan binds least strongly."
Unleashing the power of AI is a game changer in advancing healthcare to improve lives,” Tan added. In this next phase of development, Paige is incorporating up to four million digitized microscopy slides across multiple types of cancer from its unmatched petabyte-scale archive of clinical data.
Bayer HealthCarePharmaceuticals Inc. GE Healthcare. GE Healthcare. Full Prescribing Information and Patient Medication Guide. Whippany, NJ; April 2022. [v] v] DOTAREM (gadoterate meglumine) Injection. Full Prescribing Information. Guerbet LLC. Princeton, NJ. April 2022. [vi] Chicago, IL; February 2020. Guerbet LLC.
Cardiovascular care has seen remarkable advancements over the decades, from innovative surgical techniques to cutting-edge pharmaceuticals. The question that looms large is how AI can alleviate these burdens, allowing healthcare professionals to spend more time with their patients rather than being bogged down by paperwork and red tape.
BAMF Health was the first site in the world to test a novel radiopharmaceutical for pancreatic cancer imaging, as a clinical trial partner to pharmaceutical company Japan-based Nihon Medi-Physics Co. Anthony Chang, PhD, of BAMF Health describes the technological infrastructure of BAMF in Michigan.
Pharmaceutical organizations are already testing the promise of AI to optimize clinical trial inclusion and exclusion criteria and prevent costly failures. This shift will not only enhance accuracy at every step of the imaging pipeline but will also reduce the overall workload on radiologists and allied staff.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content